02.05.2024 - BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; Cyclacel or the Company ), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today . Seite 1